Text Size

An Evaluation of California's Experiment With HOPE

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
University of California, Irvine
University of California, Los Angeles
Information provided by:
Pepperdine University
ClinicalTrials.gov Identifier:
NCT01237691
First received: November 1, 2010
Last updated: August 9, 2011
Last verified: August 2011
History of Changes

November 1, 2010
August 9, 2011
November 2010
October 2012   (final data collection date for primary outcome measure)
Days incarcerated [ Time Frame: 24 months ] [ Designated as safety issue: No ]
Total number of days incarcerated in jail or prison
Same as current
Complete list of historical versions of study NCT01237691 on ClinicalTrials.gov Archive Site
  • % positive drug tests [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    Percentage of random and scheduled drug tests that test positive for illicit drugs
  • %Missed [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    Percentage of parole appointments that are missed.
  • Revocation rate [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    Percentage of parolees that are revoked from probation and returned to prison for either a technical violation or on a new charge.
  • New arrests [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    Number of new arrests.
  • Perceptions of risk of detection [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    Parolees perceived risk of detection for drug use
  • % positive drug tests [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    Percentage of random and schedule drug tests that test positive for illicit drugs
  • %Missed [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    Percentage of probation appointments that are missed.
  • Revocation rate [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    Percentage of parolees that are revoked from probation and returned to prison for either a technical violation or on a new charge.
  • New arrests [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    Number of new arrests.
  • Perceptions of risk of detection [ Time Frame: 24 months ] [ Designated as safety issue: No ]
    Parolees perceived risk of detection for drug use
Not Provided
Not Provided
 
An Evaluation of California's Experiment With HOPE
Phase 1 Study of California's HOPE Experiment

The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group.

The California HOPE pilot program is being implemented under the authority granted in Penal Code 5058.1. The phase I evaluation is intended to assess whether or not frequent drug testing and immediate short-term incarceration for drug use and/or other violations and mandated drug treatment for multiple violations, reduces the recurrence of drug use and/or other violation behaviors by California parolees assigned to the study group compared with parole-as-usual.
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Drugs of Abuse
  • Behavioral: HOPE supervision
    HOPE entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). HOPE includes regular random drug testing.
    Other Names:
    • HOPE
    • COPE
  • Behavioral: Parole-as-usual
    Parolees are supervised under standard parole supervision practice in California.
    Other Name: Routine parole
  • Experimental: HOPE supervision
    Parolee supervised under California's new HOPE parole model.
    Intervention: Behavioral: HOPE supervision
  • Active Comparator: Parole-as-usual
    Parolees supervised under California parole-as-usual.
    Intervention: Behavioral: Parole-as-usual
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
105
March 2013
October 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Assigned to the Sacramento Metro IV Parole Unit.
  • Released from a term of return-to-custody for a violation for, or involving, the use of drugs.
  • Have a maximum controlling discharge date at least one year from the date of release from the return-to-custody term.

Exclusion Criteria:

  • History of convictions for crimes that require registration under Penal Code Section 290.
Male
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01237691
SPPN1110F01
Yes
Angela Hawken, Pepperdine University
Pepperdine University
  • University of California, Irvine
  • University of California, Los Angeles
Principal Investigator: Angela Hawken, PhD Pepperdine University
Pepperdine University
August 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP